Associate Director, Global Proteomics

Job Description: About Innovative Medicine. Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine We are searching for the best talent for an Associate Director, Global Proteomics to be located in Cambridge, MA. Do you want to use your hard earned skills and drive to make a difference in the lives of patients? This team and platform lead role combines scientific depth, operational leadership, and strong cross functional collaboration to deliver across the Johnson & Johnson portfolio. The candidate will lead Global Proteomics, one of three platform pillars within the Discovery Proteomic Platforms (DPP) group - alongside Chemoproteomics and Immunopeptidomics - in the Discovery Technologies and Molecular Pharmacology (DTMP) department of Therapeutics Discovery. Lead a motivated team dedicated to deploying groundbreaking mass spectrometry proteomics technologies as we, together, tackle the challenges of target identification and validation as well as therapeutic optimization. Work across a leading multiomics organization to provide integrated insights across a variety of 'omics layers. Your team's data shapes study design, compound selection, and program direction across a broad portfolio with influence earned through scientific rigor and partnership with program teams across Oncology, Immunology, and Neuroscience. Work in an exciting, interdisciplinary environment, overlapping the different stages of the discovery pipeline. With your help, we will drive development of medicines for our patients! You will be responsible forManaging and developing a team of wet‑lab scientists; build an inclusive, feedback‑rich culture focused on scientific excellence, safety, and continuous improvement. Establishing delivery frameworks with clear SLAs, cycle‑time targets, and prioritization aligned to portfolio decision points and pre‑portfolio (platform‑building) needs. Planning, overseeing, and performing/providing oversight for proteomics studies supporting target ID/validation, MoA elucidation, biomarker discovery, and therapeutic optimization. Partnering closely with bioinformatics/data science to ensure robust QC, FAIR data practices, and decision‑ready analyses as well as to apply computational and AI-enabled approaches to proteomic data interpretation and decision support. Partnering across the multiomics organization to design integrated studies and interpret proteomic data alongside transcriptomic, genomic, and spatial readouts, delivering conclusions no single layer supports on its own. Translating sophisticated proteomics findings for non‑experts and governance forums; influence study design and portfolio strategy across biology, chemistry, biologics, safety, DMPK, and clinical translation. Shaping the platform's priorities and roadmap, balancing sustained portfolio delivery with investment in new capability. Qualifications / RequirementsEducationA Doctorate (in Analytical Chemistry, Biochemistry, Molecular Biology, Pharmacology or a related field) is required Experience and Skills 8+ years of hands‑on experience in a proteomics laboratory, including 4+ years in a drug discovery setting. Proven track record leading mass spectrometry operations (people, platforms, and processes) with measurable portfolio impact. Hands‑on proficiency with LC and MS platforms, including (examples, not exhaustive): LC: Waters ACQUITY/nanoACQUITY, Thermo Vanquish Neo, Evosep One, Dionex UltiMate 3000 MS: Thermo Orbitrap Exploris, Orbitrap Eclipse, Orbitrap Fusion Lumos ; Bruker timsTOF Proficiency in automated, plate-based proteomic workflows and